From biomarkers to therapeutic targets—the promises and perils of long non-coding RNAs in cancer

T Gutschner, G Richtig, M Haemmerle… - Cancer and Metastasis …, 2018 - Springer
… Here, we will highlight prime examples of lncRNAs that serve as marker for cancer
progression or therapy response and which might represent promising therapeutic targets. …

The promise and perils of immunotherapy

S Lesch, S Gill - Blood Advances, 2021 - ashpublications.org
… of powerful therapeutic strategies to treat these diseases. In contrast to conventional therapies
that … are more akin to targeted therapies because they are mechanistically driven and are …

Targeting the p53 signaling pathway in cancer therapy–the promises, challenges and perils

AH Stegh - Expert opinion on therapeutic targets, 2012 - Taylor & Francis
Introduction: Research over the past three decades has identified p53 as a multi-functional
transcription factor. p53 influences myriad, highly diverse cellular processes, and represents …

Oncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perils

D Torti, L Trusolino - EMBO molecular medicine, 2011 - embopress.org
… enrich the catalogue of therapeutic targets, the task of developing therapies suitable for
successful … Yet, the success of therapies that target specific oncoproteins in molecularly defined …

The promise and peril of targeting cell metabolism for cancer therapy

JM Weiss - Cancer Immunology, Immunotherapy, 2020 - Springer
… itaconate production in resident macrophages remain to be determined, this metabolite
facilitates tumor progression in the peritoneal cavity and may represent a novel therapeutic target

The promise and perils of 'targeted therapy'of advanced ovarian cancer

M Markman - Oncology, 2008 - karger.com
… of ‘targeted’ therapy in ovarian cancer will focus on molecular targets of documented relevance
… However, the relevance of HER-2 as a molecular therapeutic target in epithelial ovarian …

The promise and perils of HDAC inhibitors in neurodegeneration

A Didonna, P Opal - Annals of clinical and translational …, 2015 - Wiley Online Library
… Histone deacetylases (HDACs) represent emerging therapeutic targets in the context of …
However, the translation of such therapeutic approach to clinics has been only marginally …

Perils and promises of therapeutic approaches for the stem cell disease fibrous dysplasia

I Saggio - Stem Cells Translational Medicine, 2019 - academic.oup.com
… deacetylase 8 (HDCA8), a zinc-dependent HDAC subtype, as potential therapeutic target for
FD. … HDAC8, a potential therapeutic target, regulates proliferation and differentiation of bone …

The promise and peril of chemical probe negative controls

J Lee, M Schapira - ACS chemical biology, 2021 - ACS Publications
… function and discover therapeutic targets. Chemical probe off-targets are a confounding factor
as the observed phenotype may be driven by inhibition of an unknown off-target instead of …

Cyclooxygenase‐2 inhibitors: promise or peril?

LJ Mengle-Gaw, BD Schwartz - Mediators of Inflammation, 2002 - Wiley Online Library
promise that the therapeutic benefits of NSAIDs could be optimized through inhibition of
COX‐2, while minimizing their adverse side effect profile associated with inhibition of COX‐1. …